What is the Prodrome of Multiple sclerosis?

Multiple Sclerosis (MS) doesn’t appear overnight. Increasingly, research suggests a period *before* a formal diagnosis – known as the prodrome – where subtle symptoms may emerge, often years before neurological changes are definitive enough for a diagnosis. These symptoms are often non-specific and can be easily attributed to other, more common conditions.

The concept of MS prodrome is gaining traction as researchers delve deeper into the early stages of the disease. understanding this phase is crucial because early diagnosis and intervention are believed to be key to managing MS effectively and potentially slowing its progression.

Early Indicators: Increased healthcare Utilization

Increased visits to the doctor are a notable indication of potential prodrome.Several studies have shown that individuals who are later diagnosed with MS tend to utilize healthcare services more frequently in the 5 to 10 years leading up to their diagnosis compared to those who do not develop MS. [[national Multiple Sclerosis Society – early Symptoms of MS]

A 2023 study involving 2,038 people with MS and 10,182 individuals without MS revealed specific patterns in healthcare utilization. Physician visits for mental health concerns or vague symptoms were elevated 14 to 15 years before MS onset. Consultations with neurologists and ophthalmologists increased 8 to 9 years before diagnosis, and visits related to musculoskeletal, sensory, and nervous system issues rose 4 to 8 years prior. [[JAMA Network Open – Temporal Patterns of Healthcare Utilization Before Multiple Sclerosis Diagnosis] These findings suggest MS may begin impacting individuals much earlier than previously thought.

Increased hospitalizations and medication use are also potential indicators of prodrome.

Common, But Concerning: Mental Health and Other Symptoms

“There does seem to be an increase in depression, anxiety, and migraine prior to MS diagnosis, but all three of those conditions are also very common in the general population, and most of those people never go on to develop MS,” explains Dr. Rima otallah, a neurologist specializing in MS. This makes identifying prodromal MS based on these symptoms alone challenging.

While these conditions, along with other suspected prodrome symptoms, aren’t currently used to identify individuals at increased risk of MS, researchers are actively investigating correlations. Dr.Otallah notes, “We’re not at a point where we can use these to predict if someone is going to go on to develop MS, but when we look back, we are noticing correlations.”